Other Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26 Drug ChannelsToday's guest post comes from Chrissy Hand, Chief Product and Commercial Officer at CoverMyMeds.OtherRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Drug Channels Today’s guest post comes from Chrissy Hand, Chief Product and Commercial Officer at CoverMyMeds. OtherRead full story Post navigation Previous: Merck KGaA acquires JSR chromatography businessNext: Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
